INDP Stock Analysis: Buy, Sell, or Hold?
INDP - Indaptus Therapeutics, Inc. Common Stock
$1.85
-0.16 (-7.96%)
▼
5d:
-25.4%
30d:
-32.48%
90d:
-42.55%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 12, 2026
Get Alerted When INDP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called INDP this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: INDP is down 25.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: INDP is down 25.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: INDP is currently trading at $1.85, which is considered oversold relative to its 30-day fair value range of $2.32 to $3.06.
Technical Outlook: Technically, INDP is in a downtrend. Immediate support is located at $1.77, while resistance sits at $2.98. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+440.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INDP is in a downtrend. Immediate support is located at $1.77, while resistance sits at $2.98. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+440.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.32 -
$3.06
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.0%)
- BULLISH: Trading 440.5% below Wall St target ($10.00)
- WARNING: Recommendation downgraded due to -25.4% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.32 -
$3.06
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.77
Resistance Level
$2.99
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.29
Wall Street Target
$10.00
(+440.5%)
Last updated: February 03, 2026 10:21 PM ET
Data refreshes hourly during market hours. Next update: 11:21 PM
Data refreshes hourly during market hours. Next update: 11:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INDP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 59 HOLD |
